Company Information

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE4088.90-45.05 (-1.09 %)
PREV CLOSE ( ) 4133.95
OPEN PRICE ( ) 4140.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18834
TODAY'S LOW / HIGH ( )4072.00 4140.05
52 WK LOW / HIGH ( )3101 4479.7
NSE4084.60-51.1 (-1.24 %)
PREV CLOSE( ) 4135.70
OPEN PRICE ( ) 4138.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4084.60 (2)
VOLUME 413095
TODAY'S LOW / HIGH( ) 4071.20 4140.60
52 WK LOW / HIGH ( )3101.6 4482.9
ChairmanSamir Mehta
Managing DirectorAman Mehta
Company SecretaryChintan Trivedi
Non Executive Independent DirectorAmeera Shah
Nayantara Bali
Manish Choksi
Nikhil Khattau
Non Independent & Non Executive DirectorJinal Mehta
Incorporation Year : 15-07 1972

Registered Office :

Address : Avirat,Thaltej Shilaj Road, Ahmedabad,
Gujarat-380059 .

Phone : 079-26599000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.